IDH-mutant anaplastic astrocytoma
MONDO:0850332An anaplastic astrocytoma carrying IDH mutations.
2874 clinical trials for this condition and its sub-types, 10 tagged with IDH-mutant anaplastic astrocytoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of IDH-mutant anaplastic astrocytoma
-
Astrocytoma, IDH-mutant, grade 4 22 trials
-
Astrocytoma, IDH-mutant, grade 2 18 trials
-
Astrocytoma, IDH-mutant, grade 3 16 trials
-
New hope for brain tumor patients: targeted drug shows promise in phase 3 trial
Disease control Recruiting nowThis study tests a drug called safusidenib in people with a type of brain tumor (glioma) that has a specific gene mutation (IDH1). The trial has three parts: one for recurrent tumors, one for high-risk tumors after standard treatment, and one for a specific tumor type after surge…
Phase 3 • Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
AI-Powered radiation adjusts in real time to fight brain tumors
Disease control Recruiting nowThis study tests a new way to deliver radiation therapy for people with diffuse glioma, a type of brain tumor. Instead of giving the same dose throughout treatment, doctors will use MRI and PET scans taken during treatment to adjust the radiation dose to target resistant areas an…
Phase 2 • Sponsor: Tata Memorial Centre • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New RNA test could spot brain tumors without surgery
Diagnosis Recruiting nowThis study is testing whether chemical marks on RNA molecules found in blood and urine can help diagnose gliomas, a type of brain tumor. Researchers will collect samples from 228 adults scheduled for brain surgery and compare them to healthy controls. The goal is to develop a non…
Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Diagnosis
Last updated Jun 27, 2026 13:07 UTC
-
Brain cancer survivors: can a home program boost your memory?
Symptom relief Recruiting nowThis study tests a home-based program called HOBSCOTCH-CA for brain cancer survivors who struggle with memory and thinking. The program involves weekly virtual sessions with a coach, teaching problem-solving and relaxation techniques. Researchers will compare two groups: one that…
Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Personalized drug test aims to outsmart refractory brain tumors
Knowledge-focused Recruiting nowThis study tests a lab technique called pharmacoscopy that analyzes a patient's tumor tissue to find which drugs might work best for them. It includes 40 adults with various aggressive or rare brain tumors that have not responded to standard treatments. The main goal is to see if…
Phase 2 • Sponsor: University of Zurich • Aim: Knowledge-focused
Last updated Sep 21, 2026 20:00 UTC